Did you know?

ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.

China Biologic Products Receives Forbes Magazine Honor

publication date: Oct 21, 2009

China Biologic Products has been named to the 2009 list of "200 Best under a Billion" for Asia, a list put together by Forbes Magazine. China Biologic, which develops and markets plasma-based pharmaceutical products, has been growing through M&A transactions in China’s heavily regulated plasma sector. To create its list, Forbes selects listed companies with revenues of under $1 billion, solid growth history and excellent prospects. More details...